key: cord-0704802-t6otdvzq authors: Van Egeren, D.; Novokhodko, A.; Stoddard, M.; Tran, U.; Joseph-McCarthy, D.; Chakravarty, A. title: Controlling long-term SARS-CoV-2 infections is important for slowing viral evolution date: 2021-04-17 journal: nan DOI: 10.1101/2021.04.10.21255251 sha: 6908cc94981f7b8af9e5372422f4e9c3fec40b38 doc_id: 704802 cord_uid: t6otdvzq The rapid emergence and expansion of novel SARS-CoV-2 variants is an unpleasant surprise that threatens our ability to achieve herd immunity for COVID-19. These fitter SARS- CoV-2 variants often harbor multiple point mutations, conferring one or more traits that provide an evolutionary advantage, such as increased transmissibility, immune evasion and longer infection duration. In a number of cases, variant emergence has been linked to long-term infections in individuals who were either immunocompromised or treated with convalescent plasma. In this paper, we explore the mechanism by which fitter variants of SARS-CoV-2 arise during long-term infections using a mathematical model of viral evolution and identify means by which this evolution can be slowed. While viral load and infection duration play a strong role in favoring the emergence of such variants, the overall probability of emergence and subsequent transmission from any given infection is low, suggesting that viral variant emergence and establishment is a product of random chance. To the extent that luck plays a role in favoring the emergence of novel viral variants with an evolutionary advantage, targeting these low-probability random events might allow us to tip the balance of fortune away from these advantageous variants and prevent them from being established in the population. The widespread deployment of biomedical interventions against SARS-CoV-2 has highlighted viral evolution as a significant potential risk in bringing the ongoing pandemic to an end. SARS-CoV-2 has a high mutational rate, similar to other RNA viruses, and a high mutational tolerance in key proteins, such as Spike, the molecular target for many biomedical interventions against the disease 1-3 . The emergence and expansion of novel SARS-CoV-2 variants over the past few months threatens to undermine the promise of a return to normalcy as a result of the newly deployed vaccines. In fact, many of these new variants are more capable of infecting cells, spreading between hosts, and/or evading natural immunity or therapeutics 4-6 . On a population level, natural selection has acted to rapidly increase the frequency of these more-fit SARS-CoV-2 variants, leading them to dominate the local viral population after emergence (Table S1 ).The emergence of fitter variants has also led in a number of cases to more severe disease outbreaks, and poses the threat of eventual reductions in vaccine efficacy 4, 5, 7, 8 . In addition to acting at the population level, natural selection has been shown to select for advantageous viral variants that are generated within individual patients infected with SARS-CoV-2. Longitudinal sequencing of SARS-CoV-2 from individual patients has revealed selection for multiple antibody-evading mutations, particularly in patients with long-term infections treated with convalescent plasma 9 . Additionally, studies have shown that individuals with impaired immune function can shed high levels of virus for weeks, creating an environment where SARS-CoV-2 is exposed to prolonged selection pressures favoring variants that can escape the immune response and/or are resistant to treatment [10] [11] [12] [13] . Understanding the factors driving the evolutionary process for SARS-CoV-2 could potentially allow us to design and use biomedical interventions in a way that hinders viral evolution, giving us the upper hand in managing the pandemic. In particular, there are several steps in the process of generating new advantageous variants that occur largely by random chance. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 17, 2021. ; https://doi.org/10.1101/2021.04. 10.21255251 doi: medRxiv preprint First, sufficient genetic diversity must be created within infected individuals through stochastic events. SARS-CoV-2 mutations are initially generated by random errors in viral replication within individuals with COVID- 19 . Deep sequencing studies have revealed that the SARS-CoV-2 viral population exists within the host as a quasispecies 14, 15 , a population structure with a large number of related sequences arising from de novo mutations that occur during the course of infection 16, 17 . Quasispecies genetic diversity has been shown to vary over time 15, 18 , and deep sequencing studies have demonstrated a role for genetic drift 19 and intrahost transmission bottlenecks 14 as the virus moves from one region of the body to another. While genetic diversity provides opportunities for advantageous mutations to arise and expand due to natural selection within individuals infected with SARS-CoV-2, genetic drift may provide a barrier to the deterministic expansion of advantageous viral mutations at lower population sizes. Next, viral variants generated within a COVID-19 patient are transmitted to new hosts. During this process, further stochasticity is introduced by the low numbers of viral particles required to start an infection in a new host, which creates a narrow transmission bottleneck 16, 17 . Consistent with this bottleneck, sequencing studies have provided conflicting results with respect to the ability of intrahost variants to transmit and establish new SARS-CoV-2 lineages that have the potential to transmit widely. While a number of studies have shown this to be the case 16, 17, 20, 21 , other studies have not been able to demonstrate transmission of viral lineages derived from intrahost evolution 11, 22, 23 . The stochasticity in inter-host transmission of specific viral lineages is compounded by the overdispersed nature of SARS-CoV-2 spread, where most onward transmission originates from a small number of individuals. Recent work suggests an important role for stochastic extinction of variants, as at least five new infections are required in order for a newly emergent variant to establish itself in the population 24 . These stochastic factors in the evolution of SARS-CoV-2 represent a potential weakness that can be exploited in the design of intervention strategies to slow viral evolution. To the extent that the stochastic contribution of drift can be increased, the deterministic contribution of natural . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 17, 2021. ; https://doi.org/10.1101/2021.04.10.21255251 doi: medRxiv preprint selection to the improvement of viral fitness can be weakened. In this study, we have used evolutionary dynamics to better understand the process by which fitter SARS-CoV-2 variants arise during infections and to identify means by which viral evolution can be slowed. To investigate mutation and selection dynamics of SARS-CoV-2 within hosts, we simulated stochastic viral evolution using a modified Wright-Fisher model (Fig. 1A , Methods). During each 12-hour replication cycle, virions from the previous generation are randomly selected with probability proportional to their fitnesses to replicate and produce a burst of Nb new viral particles in the next generation. Each replicating virion has a constant probability of generating a new single point mutation that is passed to all of its Nb progeny. The total number of virions present in each generation is given by estimates from sputum RT-PCR measurements 25 (Fig. 1B, Methods). Unless stated, the parameter values for the simulations are those given in Table 1 . Over the course of a typical-length COVID-19 infection (23 days), our simulations show that viral variants with point mutations that increase the replication probability by 20-50% (selection coefficients of 0.2-0.5) expand significantly more than variants with neutral or weakly deleterious fitness effects (Fig. 1C ). This expansion of fitter variants increases the probability that at least one viral particle with a specific beneficial mutation will be transmitted to a new host (Fig. 1D , Methods). Individuals are more likely to pass on beneficial variants if transmission occurs later in the infection, since the frequency of these variants increases over time due to selection. Assuming these variants are also able to spread through the population with a moderate transmission advantage, new lineages with advantageous single mutations are rapidly created at the population level (Fig. 1E) . These results suggest that selection for beneficial single point mutations within COVID-19 patients increases the rate at which fitter SARS-CoV-2 lineages establish at a population level. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Viral load dynamics vary significantly between COVID-19 patients. To assess the evolutionary consequences of this variation, we simulated viral replication and transmission of variants for patients with different viral load kinetics (Fig. 2) . Patients with longer periods of peak viral load were able to transmit fitter SARS-CoV-2 variants more efficiently ( Fig. 2A) . On the other hand, decreasing viral load decreased the probability that fitter variants generated within a patient would be transmitted (Fig. 2B ). Both of these observations indicate that the strength of selection increases as the number of replicating viruses over the course of an infection increases. Many of the reported new SARS-CoV-2 variants are defined by more than one point mutation. One of these variants that arose during long-term SARS-CoV-2 infection within an immunocompromised individual included a mutation that reduced infectivity but conferred resistance to neutralizing antibodies, which was offset by a mutation that increased infectivity 9 . These observations suggest that highly-fit mutation combinations that require transit through a deleterious intermediate state (i.e., crossing a fitness valley) may be generated within COVID-19 patients with longer infection durations. To investigate the rate at which these variants are generated within hosts, we modeled a multistep mutation process where beneficial mutation combinations are created from deleterious intermediates that only have some of the mutations found in the beneficial combination (Fig. 3A) . Beneficial two-mutation combinations exist at very low frequencies over the timescale of a typicallength SARS-CoV-2 infection, but increase in frequency within hosts that have prolonged infections (Fig. 3B ). This increase in variant frequency that occurs within hosts due to selection corresponds to an increase in the probability the beneficial two-mutation variant will be transmitted . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 17, 2021. 6 ( Fig. 3C) . Therefore, patients with longer SARS-CoV-2 infections are more likely to generate a variant with multiple mutations. On a population level, these individuals who produce and shed virus for long periods (> 30 days after symptom onset) increase the production rate of new variants with multiple mutations. Increasing the proportion of COVID-19 patients with prolonged SARS-CoV-2 shedding increases the rate at which new, fitter variants with two mutations are produced ( Fig. 3D ). Several steps are required for a new SARS-CoV-2 variant to be generated and established in the population (Fig. 4A ), and each of these steps represents a potential choke point for viral evolution that can be exploited in the design of interventions. First, a new variant must be generated through mutation and expand within a host. The efficiency of generating and selecting advantageous variants within COVID-19 patients can be reduced by biomedical interventions that reduce viral load within patients or reduce the frequency of long-term infections which lead to viral transmission (Fig. 4B ). Variants then must be transmitted to additional hosts to establish within the population. Reducing the number of viral particles transmitted to new hosts (for example, through mask wearing or vaccination) will also slow the rate of emergence of advantageous variants (Fig. 4B ). Finally, interventions specifically aimed at reducing the transmissibility of the new variant would also reduce their probability of spreading widely (Fig. 4B ). This could be achieved by deploying a patchwork of vaccines and other prophylactics that target distinct epitopes, deliberately increasing the diversity of biomedical interventions to provide a more challenging evasion landscape for the virus. Taken together, our simulation results suggest that there are several low-probability stochastic events that are important for SARS-CoV-2 variant emergence and that interventions targeting these events can slow SARS-CoV-2 evolution. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This work, along with other recent findings on the stochastic nature of SARS-CoV-2 transmission 24 , suggests strategies that can be used to suppress the emergence of these fitter viral variants, thereby slowing the evolution of SARS-CoV-2. First, long-term SARS-CoV-2 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 17, 2021. ; https://doi.org/10.1101/2021.04.10.21255251 doi: medRxiv preprint infections (lasting longer than 30 days) should be treated as a serious public health concern, regardless of the presence of symptoms. Our work suggests that the low frequency of such longterm cases belies the threat that they pose to public health. In particular, asymptomatic long-term infections still transmit [10] [11] [12] [13] We note that detecting long-term infections with SARS-CoV-2 represents a major logistical challenge in its own right-a widely deployable method for distinguishing long-term infections from spurious PCR results is an unmet need at present. While viral culture can be used to confirm the presence of replication-competent virus 37 , logistical constraints (such as turnaround time and the requirement for Biosafety Level 3 containment) limit its clinical use 38 . Subgenomic RNA (sgRNA) has been proposed as a biomarker for actively replicating virus 39 , but this remains controversial at present 40 . Therefore, there is an urgent need to develop a validated biomarker for viral replication in long-term infections. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Our work also suggests reasons for concern if intrahost evolution in long-term SARS-CoV-2 infections is not addressed directly. As intrahost evolution leads to faster generation of beneficial variants at a population level, new waves of transmission driven by fitter viral variants can be expected to arise as a result of untreated long-term infections. Our results also suggest another evolutionary incentive favoring increased infection duration, since long-term SARS-CoV-2 infections increase the rate at which the virus evolves. To the extent that this evolution is shaped by immune evasion, this study also points out an evolutionary route that is open to SARS-CoV-2, by which the virus can evolve to become progressively more lethal. Notably, while this potential risk conflicts with recent work that has conjectured that SARS-CoV-2 evolution may lead to progressive decreases in viral virulence 41 We used a modified Wright-Fisher evolutionary model to investigate viral mutation and selection dynamics within individuals with COVID-19. This model assumes that SARS-CoV-2 virions replicate in discrete generations of length tg and that each replicating virion produces a fixed burst size of new virions Nb. The total number of virions present at each generation was . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 17, 2021. ; https://doi.org/10.1101/2021.04.10.21255251 doi: medRxiv preprint estimated from nasopharyngeal swab and sputum qRT-PCR measurements after diagnosis 25 . where Nt is the total number of virions in the current generation and Nb is the burst size. Each virion from the previous generation has a probability of reproducing and contributing Nb virions to the next generation that is proportional to its fitness. During each replication, there is a constant probability of generating a particular mutation that will be present in all Nb virions that are produced by that parent virion. Parameter values used for simulations are given in Table 1 . The probability that a transmission event that occurs within a particular time window during infection was estimated by assuming new infections are initiated by Ntrans virions sampled uniformly at random from the transmission period which go on to establish a new infection. Therefore, the probability that at least one virion with a specific mutation is passed on is 1 − (1 − ) ! !"#$% , where f is the fraction of virions with the mutation that existed within the transmission window. A newly-generated variant present in a single patient will initially spread stochastically to new hosts, the success of which will determine whether the variant will survive in the population. We modeled this stochastic spread as a branching process in which infected individuals infect on average R0 new hosts. More specifically, each infected individual transmits to X new hosts, where . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 17, 2021 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 17, 2021 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 1 . Table 1 . Table 1 . Table 1 , with 0.1% of new infections lasting >30 days after symptom onset. The "reduced transmissibility" condition refers to a 90% reduction in the transmission advantage of the variant, leading to an R0 of 1.05. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This list is not comprehensive, and new data are constantly being reported. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 17, 2021 share the N501Y mutation 56 . . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 17, 2021. ; https://doi.org/10.1101/2021.04.10.21255251 doi: medRxiv preprint Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies Risk of evolutionary escape from neutralizing antibodies targeting SARS-CoV-2 spike protein New SARS-CoV-2 Variants -Clinical, Public Health, and Vaccine Implications Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England Decreased neutralization of SARS-CoV-2 global variants by therapeutic antispike protein monoclonal antibodies Emergence and rapid spread of a new severe acute respiratory syndromerelated coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence SARS-CoV-2 evolution during treatment of chronic infection Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity Compartmentalized Replication of SARS-Cov-2 in Upper vs. Lower phylogenies and the quantification of intra-host genomic diversity of viral samples Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 SARS-CoV-2 within-host diversity and transmission Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Dynamics of severe acute respiratory syndrome coronavirus 2 genome variants in the feces during convalescence SARS Coronavirus-2 variant tracing within the first Coronavirus Disease 19 clusters in northern Germany High Resolution analysis of Transmission Dynamics of Sars-Cov-2 in Two Major Hospital Outbreaks in South Africa Leveraging Intrahost Diversity Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 Patients With Coronavirus Disease Population Bottlenecks and Intra-host Evolution During Human-to Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation? Inference of Active Viral Replication in Cases with Sustained Positive Reverse Transcription-PCR Results for SARS-CoV-2 SARS-CoV-2 Total and Subgenomic RNA Viral Load in Hospitalized Patients Immunological characteristics govern the transition of COVID-19 to endemicity Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission Pathogenesis of the 1918 Pandemic Influenza Virus None. DVE, MS, and AC conceived the original study design. DVE and AC designed the mathematical modeling approach and wrote the first draft. DVE conducted the modeling, with input from MS and AC. AN and UT contributed text to the Introduction, Discussion and Supplemental Materials.All authors edited and provided input into the manuscript.